Endothelial function in children with OSA and the effects of adenotonsillectomy

Kate C C Chan1, Chun T Au1, Ping Chook1

  • 1Department of Pediatrics, The Chinese University of Hong Kong, Shatin, Hong Kong.

Chest
|October 3, 2014
PubMed

Insights

Children with obstructive sleep apnea (OSA) have impaired endothelial function (FMD), but treatment like adenotonsillectomy can reverse this. This study investigated FMD changes in children with OSA before and after treatment.

Area of Science:

  • Pediatric Pulmonology
  • Cardiovascular Health
  • Sleep Medicine

Background:

  • Childhood obstructive sleep apnea (OSA) is linked to potential cardiovascular risks.
  • Endothelial dysfunction, measured by flow-mediated dilation (FMD), is a key indicator of vascular health.
  • The impact of OSA on pediatric endothelial function and treatment effects remains unclear.

Purpose of the Study:

  • To compare FMD in children with OSA versus healthy controls.
  • To assess the effect of OSA treatment on FMD in pediatric patients.

Main Methods:

  • Paired case-control study involving 63 children (6-18 years) with OSA and matched controls.
  • Polysomnography (PSG) confirmed OSA and assessed obstructive apnea hypopnea index (OAHI).
  • Flow-mediated dilation (FMD) measured endothelial function; adenotonsillectomy (AT) was the primary treatment intervention.

Main Results:

  • Children with OSA exhibited significantly lower FMD compared to controls (P=.04).
  • Adenotonsillectomy in OSA patients led to a significant reduction in OAHI (P<.001).
  • Following AT, a significant improvement in FMD was observed in the treatment group (P<.001).

Conclusions:

  • Pediatric OSA is associated with reduced endothelial function (FMD).
  • Adenotonsillectomy effectively improves endothelial function in children with OSA.
  • Treatment reverses endothelial dysfunction in children suffering from OSA.
Abstract

Related Concept Videos

Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
3.8K
Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
889
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
603
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
16.5K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
624
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
656